Concepedia

D End

DE

Statistics

Publications

14

Citations

1.1K

H-Index

14

Active since

1977

Affiliations

Johnson & Johnson (United States)(Current)

National Institutes of Health

Springhouse

Health and Human Development (2HD) Research Network

Janssen (United States)

D End is an author at Johnson & Johnson (United States) specializing in pharmacology, medicine, and oncology.

Publications per year

1977–2008

14

Publications

14

Phase I and Pharmacokinetic Study of Farnesyl Protein Transferase Inhibitor R115777 in Advanced Cancer

J. Zujewski, Ivan D. Horak, C.J. Bol et al. · Journal of Clinical Oncology · 2000 · 265 citations

, , +15

Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor

Karen Huff, D End, Gordon Guroff · The Journal of Cell Biology · 1981 · 263 citations · Full text

, , +14

Synthesis Routes Towards the Farnesyl Protein Transferase Inhibitor ZARNESTRA<sup>TM</sup>

Patrick Angibaud, Marc Venet, Walter Filliers et al. · European Journal of Organic Chemistry · 2004 · 119 citations

, , +14

Preclinical antitumor activity and pharmacodynamic studies with the farnesyl protein transferase inhibitor R115777 in human breast cancer.

Lloyd R. Kèlland, Victoria Smith, Melanie Valenti et al. · PubMed · 2001 · 96 citations

, , +13

Farnesyltransferase inhibitor, R115777, reverses the resistance of human glioma cell lines to ionizing radiation

Caroline Delmas, Christophe Héliez, Elizabeth Cohen–Jonathan et al. · International Journal of Cancer · 2002 · 88 citations · Full text

, , +14

1–5 of 14